• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制瘤素M可激活甾醇抑制的肝细胞中低密度脂蛋白受体基因的转录。

Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.

作者信息

Liu J, Grove R I, Vestal R E

机构信息

Molecular Pharmacology Research Laboratory, Department of Veterans Affairs Medical Center, Boise, Idaho 83702.

出版信息

Cell Growth Differ. 1994 Dec;5(12):1333-8.

PMID:7696181
Abstract

Oncostatin M (OM), a cytokine produced by macrophages and activated T cells, has been shown to be a potent inducer of liver low density lipoprotein receptor (LDLR) activity by increasing LDL uptake and cell surface LDLR number in HepG2 cells. To investigate whether OM regulates the transcription of the LDLR gene and if the effect is independent of the sterol pathway, we examined the effects of OM on the promoter activity of the LDLR gene and the expression of LDLR mRNA. HepG2 cells were transfected with hybrid genes containing three different lengths of DNA fragments from the 5' flanking region of the LDLR gene that were fused to the coding region of the chloramphenicol acetyltransferase (CAT) gene. OM induced an approximately 3-fold increase in CAT activities in pLDLR-CAT vector-transfected cells that were incubated in lipoprotein-depleted medium and a 6-fold increase in CAT activities when the transfected cells were treated with sterols. OM stimulated similar increases in CAT activities in HepG2 cells transfected with pLDLR-CAT 234, pLDLR-CAT 1563, and pLDLR-CAT 6500, suggesting that the essential cis-acting element that mediates the OM effect is located within the 177 base pairs upstream of the transcription start site of the LDLR gene. Examination of the regulation of the endogenous LDLR mRNA expression by OM gave results similar to those in transfected cells. OM increased the levels of mRNA of LDLR, regardless of the presence or absence of lipoprotein and sterols. These data suggest that the up-regulation of the LDLR by OM is at the transcriptional level through a nonsterol mediated mechanism.

摘要

抑瘤素M(OM)是一种由巨噬细胞和活化T细胞产生的细胞因子,已被证明可通过增加低密度脂蛋白(LDL)摄取和HepG2细胞表面LDL受体(LDLR)数量,成为肝脏LDLR活性的有效诱导剂。为了研究OM是否调节LDLR基因的转录,以及该效应是否独立于固醇途径,我们检测了OM对LDLR基因启动子活性和LDLR mRNA表达的影响。用含有来自LDLR基因5'侧翼区三种不同长度DNA片段的杂交基因转染HepG2细胞,这些片段与氯霉素乙酰转移酶(CAT)基因的编码区融合。在脂蛋白缺乏培养基中培养的pLDLR-CAT载体转染细胞中,OM诱导CAT活性增加约3倍,当转染细胞用固醇处理时,CAT活性增加6倍。在转染了pLDLR-CAT 234、pLDLR-CAT 1563和pLDLR-CAT 6500的HepG2细胞中,OM刺激CAT活性有类似增加,表明介导OM效应的必需顺式作用元件位于LDLR基因转录起始位点上游177个碱基对内。对OM对内源性LDLR mRNA表达的调节研究结果与转染细胞中的结果相似。无论有无脂蛋白和固醇,OM均可增加LDLR的mRNA水平。这些数据表明,OM对LDLR的上调作用是通过非固醇介导的机制在转录水平上实现的。

相似文献

1
Oncostatin M activates low density lipoprotein receptor gene transcription in sterol-repressed liver cells.制瘤素M可激活甾醇抑制的肝细胞中低密度脂蛋白受体基因的转录。
Cell Growth Differ. 1994 Dec;5(12):1333-8.
2
Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.C/EBPβ显性负性突变体对抑瘤素M诱导的低密度脂蛋白受体基因转录的阻断作用
Biochem J. 2006 Jul 1;397(1):101-8. doi: 10.1042/BJ20060044.
3
Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.抑瘤素M对低密度脂蛋白受体(LDLR)转录的诱导作用是由细胞外信号调节激酶信号通路和LDLR启动子的重复3元件介导的。
J Biol Chem. 1999 Mar 5;274(10):6747-53. doi: 10.1074/jbc.274.10.6747.
4
Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.抑瘤素M诱导Egr-1表达先于HepG2细胞中低密度脂蛋白受体的上调。
Cell Growth Differ. 1993 Jul;4(7):611-6.
5
Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro.重组制瘤素M在体外刺激HepG2细胞和大鼠原代肝细胞产生急性期蛋白。
J Immunol. 1992 Mar 15;148(6):1731-6.
6
Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription.固醇调节元件结合蛋白介导氟伐他汀对胞质3-羟基-3-甲基戊二酰辅酶A合酶转录的影响。
Arch Biochem Biophys. 2000 Feb 15;374(2):286-92. doi: 10.1006/abbi.1999.1600.
7
Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.抑瘤素M特异性受体介导乳腺癌细胞生长的抑制及原癌基因c-myc的下调。
Cell Growth Differ. 1997 Jun;8(6):667-76.
8
Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M.抑瘤素M对肝脏低密度脂蛋白受体转录激活的新机制
J Lipid Res. 1997 Oct;38(10):2035-48.
9
Cell and tissue-type specific expression of Ras-related GTPase RhoB.Ras相关GTP酶RhoB的细胞和组织类型特异性表达
Anticancer Res. 1999 May-Jun;19(3A):1681-8.
10
Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.雌激素受体在雌激素受体阴性人乳腺癌细胞中的表达:对表皮生长因子受体(EGF-R)和转化生长因子α(TGFα)基因表达的调节
J Cell Biochem. 1994 Mar;54(3):289-98. doi: 10.1002/jcb.240540305.

引用本文的文献

1
Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells.细胞因子 Oncostatin M 通过激活 Janus 激酶,降低肝细胞中 PCSK9 的表达。
J Lipid Res. 2011 Mar;52(3):518-30. doi: 10.1194/jlr.M010603. Epub 2010 Dec 31.
2
Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.C/EBPβ显性负性突变体对抑瘤素M诱导的低密度脂蛋白受体基因转录的阻断作用
Biochem J. 2006 Jul 1;397(1):101-8. doi: 10.1042/BJ20060044.
3
Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells.
酪氨酸激酶依赖性调节人乳腺腺癌SKBR-3细胞中3-羟基-3-甲基戊二酰辅酶A还原酶
Biochem J. 1998 Feb 15;330 ( Pt 1)(Pt 1):241-6. doi: 10.1042/bj3300241.